Cogstate Ltd (ASX:CGS)
Cogstate Ltd is an Australia-based neuroscience technology company. The Company provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The Company's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.